| FIDCX | RMBNX | FIDCX / RMBNX | |
| Total Expense Ratio | 1.97 | 2.14 | 92% |
| Annual Report Gross Expense Ratio | 1.98 | 2.14 | 93% |
| Fund Existence | 27 years | 21 years | - |
| Gain YTD | 4.111 | 2.187 | 188% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 2500 | 40% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 295M | 218M | 135% |
| Annual Yield % from dividends | 0.53 | 0.70 | 76% |
| Returns for 1 year | -9.12 | -5.78 | 158% |
| Returns for 3 years | 7.10 | -5.29 | -134% |
| Returns for 5 years | -0.32 | 39.41 | -1% |
| Returns for 10 years | 1.97 | 44.45 | 4% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IVGTX | 11.07 | -0.06 | -0.54% |
| VY® Morgan Stanley Global Franchise S | |||
| MGIAX | 45.99 | -0.27 | -0.58% |
| MFS International Intrinsic Value A | |||
| MOSAX | 9.88 | -0.06 | -0.60% |
| MassMutual Overseas A | |||
| GIRMX | 29.81 | -0.31 | -1.03% |
| Goldman Sachs Emerging Markets Eq Inv | |||
| GMOUX | 33.48 | -0.41 | -1.21% |
| GMO International Equity I | |||